Enter assignee name

CIPO Patents = 1

Forward Citations = 173

Loading Chart...

7 inventors (with patents filed for the assignee):

Tetsuo Nakamura (8 out of 13 patents)

Shunji Mishiro (4 out of 8 patents)

Hiroaki Okamoto (4 out of 5 patents)

4. Kunio Ando (2 out of 11 patents)

5. Junichi Kishimoto (1 out of 4 patents)

6. Yoshiyuki Nishikawa (1 out of 1 patent)

7. Sachiko Goto (1 out of 1 patent)

8. Sachiko Goto (0 patent)

11 patents: Sort by Forward Citations

1. 6103485 - Non-A non-B hepatitis related nucleic acids proteins peptides antigens (2000-08-15),

2. 5856458 - Oligonucleotide primers, and their application for high-fidelity (1999-01-05),

3. 5766867 - Non-A, non-B hepatitis related nucleic acids, proteins, peptides, (1998-06-16),

4. 5576299 - Formulated medicine for treatment and prevention of opportunistic (1996-11-19),

5. 5550016 - Oligonucleotides of HCV, primers and probes therefrom, method of (1996-08-27),

6. 5428145 - Non-A, non-B, hepatitis virus genome, polynucleotides, polypeptides, (1995-06-27),

7. 5427909 - Oligonucleotides and determination system of HCV genotypes (1995-06-27),

8. 5198419 - Formulated medicines for enhancing the efficacy of beta-lactam (1993-03-30),

9. 5176994 - Non-A, Non-B hepatitis virus genome RNA, cDNA and virus antigen protein (1993-01-05),

10. 5128334 - Analgesic and anti-inflammatory medicine (1992-07-07),

11. 5077193 - Non-A, Non-B hepatitis virus genome RNA, cDNA and virus antigen protein (1991-12-31),

Immuno Japan Inc. is a leading biotechnology company specializing in the development and production of innovative immunotherapy products. With a strong focus on research and development, Immuno Japan is committed to advancing the field of immunology through cutting-edge technology and scientific excellence. Our mission is to improve the quality of life for patients by providing effective and personalized treatment options. Learn more about our products and services on our website.

Profile summary based on public USPTO records.